97-LB: safety and glycemic outcomes of the MiniMed advanced hybrid closed-loop (AHCL) system in subjects with T1D

AL Carlson, BW Bode, RL Brazg, MP Christiansen… - Diabetes, 2020 - Am Diabetes Assoc
Background: Automated insulin delivery systems improve glycemic control including time
spent in, below and above range (TIR, TBR and TAR, respectively) in people with T1D. A
next generation system, the MiniMed TM AHCL system, that offers a target set point (SP) of
100 or 120mg/dL, autocorrects to 120mg/dL every 5 mins and has fewer Auto Mode exits,
was evaluated. Methods: A 16-site, single-arm, in-home trial of the AHCL system in 39
adolescents (14-21yrs) and 118 adults (≥ 22yrs) with T1D was conducted. After a baseline …

[引用][C] 97-LB: Safety and Glycemic Outcomes of the MiniMed Advanced Hybrid Closed-Loop (AHCL) System in Subjects with T1D American Diabetes Association 80th …

AL Carlson, BW Bode, RL Brazg - Virtual
以上显示的是最相近的搜索结果。 查看全部搜索结果